Log In
Saturday 24th August 2019

Botox could soon be offered to migraine sufferers

11th May 2012

The drug and medicine watchdog has indicated that Botox cold soon be available on the NHS in England and Wales to patients with chronic migraines.


Final draft guidelines by the National Institute for Health and Clinical Excellence (NICE), due to be published in June, have recommended that the anti-wrinkle drug could be used when other drugs have not worked for patients.

Professor Carole Longson, the director of the health technology evaluation centre at NICE, said: “Chronic migraines are extremely debilitating and can significantly affect a person's quality of life.

“We are pleased that the committee has been able to recommend Botox as a preventative therapy for those adults whose headaches have not improved despite trying at least three other medications and whose headaches are not caused by medication overuse.”

Botox gained approval for treating migraine in this country in 2010 and initially NICE said there was insufficient evidence that it was cost effective.

However, after asking the manufacturer Allergan to provide more proof, NICE has now said that Botox can be used for some migraine patients in a treatment it believes will cost the NHS £349.40 for every 12-week cycle.

The Migraine Trust has welcomed the recommendation and chief executive Wendy Thomas said: “For patients who suffer from this condition, Botox may offer a safe and effective preventative treatment option to help them manage their migraine and improve their quality of life.”

The British Association for the Study of Headache said Botox can be a life changing treatment for some patients.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2019